Nutex Health Inc (NUTX) Stock Analysis

Verdict: BUY

Deeply undervalued micro-hospital operator transitioning to high-margin profitability with massive FCF yield and strong insider support.

Investment score: 74/100

Analysis as of

Is Nutex Health Inc stock worth reviewing? AI model thesis

The AI model identifies NUTX as a high-conviction buy based on its extreme valuation gap relative to peers, high earnings surprise magnitude (89%), and robust free cash flow generation.

7-factor investment score

Nutex Health Inc opportunities and risks

What speaks for NUTX

What speaks against NUTX

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
NUTX6.2x1.3x3.5x51.3%21.2%31.2%
SGRYn/a0.6x6.1x21.7%-2.3%10.2%
SNDAn/a4.6x689.1x-29.9%-24.2%-2.5%
ARDT21.0x0.3x8.0x30.0%1.2%12.8%
USPH470.9x1.7x15.4x21.8%0.3%5.1%
CYHn/a0.0x2.1x58.1%-1.3%-43.7%
Peer mediann/a0.6x8.0x21.8%-1.3%5.1%

Frequently asked questions about Nutex Health Inc (NUTX)

Is NUTX stock a good investment?

The cached TradeMates AI model rates Nutex Health Inc as BUY with an investment score of 74/100. The AI model identifies NUTX as a high-conviction buy based on its extreme valuation gap relative to peers, high earnings surprise magnitude (89%), and robust free cash flow generation. This is algorithmic model output, not personal investment advice.

Is NUTX stock a buy?

The TradeMates model verdict for NUTX is BUY with an investment score of 74/100. Treat this as a model signal to review, not a personal buy recommendation.